These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8111704

  • 1. Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.
    Hida T, Kuwabara M, Ariyoshi Y, Takahashi T, Sugiura T, Hosoda K, Niitsu Y, Ueda R.
    Cancer; 1994 Mar 01; 73(5):1377-82. PubMed ID: 8111704
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N.
    Cancer; 1996 Aug 01; 78(3):416-21. PubMed ID: 8697385
    [Abstract] [Full Text] [Related]

  • 3. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi.
    Mathieu A, Remmelink M, D'Haene N, Penant S, Gaussin JF, Van Ginckel R, Darro F, Kiss R, Salmon I.
    Cancer; 2004 Oct 15; 101(8):1908-18. PubMed ID: 15386340
    [Abstract] [Full Text] [Related]

  • 4. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M, Akpolat I, Kandemir B.
    Saudi Med J; 2003 May 15; 24(5):493-8. PubMed ID: 12847624
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T, Yasuda Y, Takaya T, Hayakawa K, Toshima S, Shibuya C, Kashiki Y, Yoshimi N, Shibayama M.
    Cancer Detect Prev; 2000 May 15; 24(3):252-7. PubMed ID: 10975287
    [Abstract] [Full Text] [Related]

  • 6. Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.
    Hida T, Ariyoshi Y, Kuwabara M, Sugiura T, Takahashi T, Takahashi T, Hosoda K, Niitsu Y, Ueda R.
    Jpn J Clin Oncol; 1993 Feb 15; 23(1):14-9. PubMed ID: 8384671
    [Abstract] [Full Text] [Related]

  • 7. Expression of p53 and glutathione S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer.
    Nakanishi Y, Kawasaki M, Bai F, Takayama K, Pei XH, Takano K, Inoue K, Osaki S, Hara N, Kiyohara C.
    Oncology; 1999 Nov 15; 57(4):318-23. PubMed ID: 10575319
    [Abstract] [Full Text] [Related]

  • 8. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M, Takada M, Kamei T, Negoro S, Kusunoki Y, Matsui K, Ryu S, Sakai N, Takifuji N, Masuda N.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [Abstract] [Full Text] [Related]

  • 9. Elevation of the placental glutathione S-transferase form (GST-pi) in tumor tissues and the levels in sera of patients with cancer.
    Tsuchida S, Sekine Y, Shineha R, Nishihira T, Sato K.
    Cancer Res; 1989 Sep 15; 49(18):5225-9. PubMed ID: 2504486
    [Abstract] [Full Text] [Related]

  • 10. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [Abstract] [Full Text] [Related]

  • 11. Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck.
    Ferruzzi E, Franceschini R, Cazzolato G, Geroni C, Fowst C, Pastorino U, Tradati N, Tursi J, Dittadi R, Gion M.
    Eur J Cancer; 2003 May 15; 39(7):1019-29. PubMed ID: 12706373
    [Abstract] [Full Text] [Related]

  • 12. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
    Zhang S, He L, Dai N, Guan W, Shan J, Yang X, Zhong Z, Qing Y, Jin F, Chen C, Yang Y, Wang H, Baugh L, Tell G, Wilson DM, Li M, Wang D.
    Oncotarget; 2016 Nov 22; 7(47):77482-77494. PubMed ID: 27813497
    [Abstract] [Full Text] [Related]

  • 13. Serum tumor markers, hypoxia-inducible factor-1α HIF-1α and vascular endothelial growth factor, in patients with non- small cell lung cancer before and after intervention.
    Liang J, Qian Y, Xu D, Yin Q, Pan HJ.
    Asian Pac J Cancer Prev; 2013 Nov 22; 14(6):3851-4. PubMed ID: 23886195
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.
    Alm El-Din MA, Farouk G, Nagy H, Abd Elzaher A, Abo El-Magd GH.
    Int J Biol Markers; 2012 Jul 19; 27(2):e139-46. PubMed ID: 22467097
    [Abstract] [Full Text] [Related]

  • 15. Serum carcinoembryonic antigen level as a surrogate marker for the evaluation of tumor response to chemotherapy in nonsmall cell lung cancer.
    Ishiguro F, Fukui T, Mori S, Katayama T, Sakakura N, Hatooka S, Mitsudomi T.
    Ann Thorac Cardiovasc Surg; 2010 Aug 19; 16(4):242-7. PubMed ID: 21057440
    [Abstract] [Full Text] [Related]

  • 16. Measurement of glutathione S-transferase pi isoenzyme in plasma, a possible marker for adenocarcinoma of the lung.
    Howie AF, Douglas JG, Fergusson RJ, Beckett GJ.
    Clin Chem; 1990 Mar 19; 36(3):453-6. PubMed ID: 2155721
    [Abstract] [Full Text] [Related]

  • 17. CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.
    Sone K, Oguri T, Nakao M, Kagawa Y, Kurowaka R, Furuta H, Fukuda S, Uemura T, Takakuwa O, Kanemitsu Y, Ohkubo H, Takemura M, Maeno K, Ito Y, Sato H, Muramatsu H, Niimi A.
    Anticancer Res; 2017 Feb 19; 37(2):935-939. PubMed ID: 28179355
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.
    Fiala O, Pesek M, Finek J, Svaton M, Sorejs O, Bortlicek Z, Kucera R, Topolcan O.
    Anticancer Res; 2016 Jan 19; 36(1):461-6. PubMed ID: 26722082
    [Abstract] [Full Text] [Related]

  • 19. [Expression of glutathione S-transferase-pi in human esophageal squamous cell carcinoma].
    Li Z, Zhang R, Luo X.
    Zhonghua Zhong Liu Za Zhi; 2001 Jan 19; 23(1):39-42. PubMed ID: 11783067
    [Abstract] [Full Text] [Related]

  • 20. Significance of glutathione S-transferase-pi as a tumor marker in patients with oral cancer.
    Hirata S, Odajima T, Kohama G, Ishigaki S, Niitsu Y.
    Cancer; 1992 Nov 15; 70(10):2381-7. PubMed ID: 1423169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.